FDA OKs Ninth Humira Biosimilar, With Interchangeability FDA OKs Ninth Humira Biosimilar, With Interchangeability

The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available later this month.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news